Cenix BioScience follows up successful RNAi-based target discovery screens with target validation study for AstraZeneca
Cenix BioScience GmbH, a leading RNA interference (RNAi)-focused contract research organization, today announced that it…
Cenix BioScience GmbH, a leading RNA interference (RNAi)-focused contract research organization, today announced that it…
Cenix BioScience GmbH, a leading RNA interference (RNAi)-focused contract research organization, today announced that it…
Cenix BioScience GmbH (Dresden), the leading specialist in advanced RNA interference (RNAi)-based research services, tod…
signed a framework research agreement to support CellCentric Ltd, a biotechnology company unlocking epigenetic control m…
Cenix BioScience GmbH (Dresden), the leading specialist in advanced RNA interference (RNAi)-based research services, tod…
Definiens AG, a global leader in Enterprise Image Intelligence Automation™, announced today the release of Cellenger®, i…